What is Stamford ASC?
Stamford ASC operates as a premier specialized surgery center, serving as a critical clinical partner for Orthopaedic & Neurosurgery Specialists (ONS). The facility is engineered to provide advanced musculoskeletal surgeries and interventional pain management treatments in an outpatient setting. By prioritizing patient-centric recovery environments, the center offers a sophisticated alternative to conventional hospital stays. Its commitment to clinical rigor is evidenced by its accreditation from the Association of Ambulatory Health Care (AAAHC) and its licensure by the Connecticut Department of Public Health, positioning it as a high-quality provider within the regional healthcare landscape.
How much funding has Stamford ASC raised?
Stamford ASC has raised a total of $48K across 1 funding round:
Stock/Share Issuance
$48K
Stock/Share Issuance (2025): $48K, investors not publicly disclosed
Key Investors in Stamford ASC
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Stamford ASC?
The infusion of capital is expected to catalyze a period of strategic growth for Stamford ASC. As the organization transitions through its current lifecycle stage, the focus will likely shift toward expanding its surgical capacity and integrating cutting-edge medical technologies to enhance patient outcomes. By leveraging this financial backing, the center aims to solidify its market presence, potentially increasing its throughput of complex orthopedic and neurosurgical procedures. Future initiatives will likely prioritize operational efficiency and the continued recruitment of top-tier surgical talent to maintain its competitive edge in the ambulatory care sector.
See full Stamford ASC company page
